 Ethan Hughes
Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oligodendroglia | 10 | 2025 | 164 | 4.330 |
Why?
| | Myelin Sheath | 8 | 2025 | 159 | 3.750 |
Why?
| | Axons | 5 | 2024 | 188 | 1.790 |
Why?
| | Remyelination | 2 | 2025 | 13 | 1.620 |
Why?
| | Demyelinating Diseases | 3 | 2025 | 82 | 1.280 |
Why?
| | Oligodendrocyte Precursor Cells | 2 | 2024 | 21 | 1.050 |
Why?
| | Neuronal Plasticity | 4 | 2024 | 263 | 1.030 |
Why?
| | Visual Cortex | 1 | 2025 | 68 | 0.900 |
Why?
| | Neurons | 10 | 2024 | 1448 | 0.890 |
Why?
| | Astrocytes | 6 | 2019 | 189 | 0.860 |
Why?
| | White Matter | 1 | 2024 | 132 | 0.780 |
Why?
| | Synapses | 6 | 2010 | 385 | 0.740 |
Why?
| | Neurogenesis | 2 | 2024 | 122 | 0.730 |
Why?
| | Neuroglia | 1 | 2021 | 166 | 0.690 |
Why?
| | Recovery of Function | 2 | 2025 | 643 | 0.690 |
Why?
| | Learning | 2 | 2022 | 390 | 0.660 |
Why?
| | Cell Communication | 2 | 2020 | 293 | 0.650 |
Why?
| | Somatosensory Cortex | 1 | 2018 | 35 | 0.580 |
Why?
| | Calcium Signaling | 1 | 2020 | 235 | 0.580 |
Why?
| | Sensation | 1 | 2018 | 50 | 0.580 |
Why?
| | Encephalitis | 4 | 2015 | 132 | 0.550 |
Why?
| | Cerebral Cortex | 4 | 2019 | 420 | 0.510 |
Why?
| | Motor Activity | 1 | 2020 | 667 | 0.490 |
Why?
| | Animals | 23 | 2025 | 34501 | 0.460 |
Why?
| | Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 9 | 0.460 |
Why?
| | Brain | 5 | 2024 | 2618 | 0.450 |
Why?
| | Central Nervous System | 1 | 2016 | 255 | 0.440 |
Why?
| | Adult Stem Cells | 1 | 2014 | 37 | 0.440 |
Why?
| | Cuprizone | 2 | 2025 | 15 | 0.410 |
Why?
| | Mice | 13 | 2025 | 16579 | 0.400 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 3 | 2015 | 202 | 0.390 |
Why?
| | Microglia | 1 | 2014 | 227 | 0.380 |
Why?
| | Hippocampus | 6 | 2015 | 795 | 0.380 |
Why?
| | Neural Stem Cells | 1 | 2013 | 137 | 0.370 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5257 | 0.350 |
Why?
| | Cell Differentiation | 2 | 2020 | 1883 | 0.350 |
Why?
| | Culture Media, Conditioned | 2 | 2009 | 108 | 0.340 |
Why?
| | Glutamic Acid | 3 | 2009 | 231 | 0.320 |
Why?
| | Homeostasis | 1 | 2013 | 605 | 0.320 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2009 | 158 | 0.300 |
Why?
| | Autoantibodies | 4 | 2010 | 1463 | 0.300 |
Why?
| | Mice, Transgenic | 3 | 2024 | 2069 | 0.250 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2005 | 93 | 0.230 |
Why?
| | Excitatory Amino Acid Transporter 2 | 1 | 2004 | 15 | 0.230 |
Why?
| | Cells, Cultured | 10 | 2019 | 4008 | 0.220 |
Why?
| | Nerve Regeneration | 1 | 2024 | 62 | 0.220 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 132 | 0.210 |
Why?
| | Motor Cortex | 2 | 2020 | 57 | 0.210 |
Why?
| | Down-Regulation | 1 | 2004 | 629 | 0.190 |
Why?
| | Nerve Tissue Proteins | 2 | 2019 | 567 | 0.180 |
Why?
| | Receptors, AMPA | 2 | 2015 | 134 | 0.180 |
Why?
| | Signal Transduction | 1 | 2014 | 4829 | 0.180 |
Why?
| | Monoamine Oxidase Inhibitors | 1 | 2020 | 15 | 0.170 |
Why?
| | Synaptic Transmission | 2 | 2015 | 260 | 0.160 |
Why?
| | Eye Proteins | 1 | 2019 | 87 | 0.150 |
Why?
| | Sensory Deprivation | 1 | 2018 | 7 | 0.150 |
Why?
| | Rats | 7 | 2015 | 5168 | 0.150 |
Why?
| | Cell Lineage | 1 | 2020 | 333 | 0.150 |
Why?
| | Multiple Sclerosis | 1 | 2023 | 434 | 0.150 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2018 | 66 | 0.150 |
Why?
| | Cell Membrane | 2 | 2016 | 722 | 0.140 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2017 | 36 | 0.140 |
Why?
| | Animals, Newborn | 2 | 2018 | 805 | 0.140 |
Why?
| | Photic Stimulation | 1 | 2018 | 240 | 0.140 |
Why?
| | Movement | 1 | 2018 | 267 | 0.130 |
Why?
| | Environment | 1 | 2018 | 347 | 0.130 |
Why?
| | Male | 7 | 2025 | 62883 | 0.130 |
Why?
| | Disease Models, Animal | 1 | 2025 | 3943 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 534 | 0.110 |
Why?
| | Endoplasmic Reticulum | 1 | 2017 | 260 | 0.110 |
Why?
| | Cell Count | 2 | 2013 | 314 | 0.110 |
Why?
| | Female | 7 | 2025 | 68127 | 0.110 |
Why?
| | Patch-Clamp Techniques | 3 | 2010 | 262 | 0.110 |
Why?
| | Stem Cells | 1 | 2018 | 578 | 0.110 |
Why?
| | Time-Lapse Imaging | 1 | 2013 | 19 | 0.110 |
Why?
| | Antibodies | 1 | 2015 | 391 | 0.100 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2010 | 113 | 0.100 |
Why?
| | Cell Death | 1 | 2013 | 348 | 0.090 |
Why?
| | Coculture Techniques | 2 | 2009 | 225 | 0.090 |
Why?
| | Mitochondria | 1 | 2017 | 844 | 0.090 |
Why?
| | Calcium | 1 | 2017 | 1178 | 0.090 |
Why?
| | Receptor Aggregation | 1 | 2010 | 10 | 0.090 |
Why?
| | Rats, Inbred Lew | 1 | 2010 | 92 | 0.090 |
Why?
| | Thrombospondins | 1 | 2009 | 7 | 0.080 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2010 | 70 | 0.080 |
Why?
| | Limbic Encephalitis | 1 | 2009 | 4 | 0.080 |
Why?
| | Memory Disorders | 1 | 2010 | 158 | 0.080 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2008 | 24 | 0.080 |
Why?
| | Cell Movement | 1 | 2013 | 937 | 0.080 |
Why?
| | Aging | 1 | 2018 | 1770 | 0.070 |
Why?
| | Humans | 10 | 2024 | 128524 | 0.070 |
Why?
| | Receptors, Eph Family | 1 | 2006 | 6 | 0.070 |
Why?
| | Autoimmune Diseases | 1 | 2010 | 423 | 0.070 |
Why?
| | Intracellular Space | 1 | 2006 | 71 | 0.070 |
Why?
| | Tandem Mass Spectrometry | 1 | 2009 | 450 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2010 | 496 | 0.060 |
Why?
| | Membrane Proteins | 2 | 2009 | 1108 | 0.060 |
Why?
| | Epitopes | 2 | 2023 | 466 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2013 | 2335 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2009 | 731 | 0.060 |
Why?
| | Receptor, trkA | 1 | 2005 | 16 | 0.060 |
Why?
| | Excitatory Amino Acid Transporter 3 | 1 | 2004 | 1 | 0.060 |
Why?
| | Amino Acid Transport System X-AG | 1 | 2004 | 3 | 0.060 |
Why?
| | Glutamate Plasma Membrane Transport Proteins | 1 | 2004 | 6 | 0.060 |
Why?
| | Excitatory Amino Acid Transporter 1 | 1 | 2004 | 5 | 0.060 |
Why?
| | Bucladesine | 1 | 2004 | 24 | 0.060 |
Why?
| | Synaptosomes | 1 | 2004 | 27 | 0.060 |
Why?
| | Receptors, GABA-A | 1 | 2005 | 96 | 0.060 |
Why?
| | Symporters | 1 | 2004 | 55 | 0.060 |
Why?
| | Neural Inhibition | 1 | 2005 | 152 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2006 | 2752 | 0.050 |
Why?
| | Proteolipids | 1 | 2023 | 30 | 0.050 |
Why?
| | Immunoglobulin G | 2 | 2023 | 837 | 0.050 |
Why?
| | Protein Transport | 1 | 2004 | 422 | 0.050 |
Why?
| | Autoantigens | 3 | 2010 | 416 | 0.050 |
Why?
| | Cytokines | 1 | 2009 | 1985 | 0.040 |
Why?
| | Dendritic Spines | 1 | 2019 | 60 | 0.040 |
Why?
| | Gray Matter | 1 | 2019 | 82 | 0.040 |
Why?
| | Biomarkers | 1 | 2009 | 3881 | 0.040 |
Why?
| | Color | 1 | 2018 | 74 | 0.040 |
Why?
| | Superoxide Dismutase-1 | 1 | 2017 | 9 | 0.030 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2019 | 206 | 0.030 |
Why?
| | Inositol 1,4,5-Trisphosphate | 1 | 2017 | 31 | 0.030 |
Why?
| | Young Adult | 2 | 2010 | 12320 | 0.030 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2017 | 69 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2017 | 184 | 0.030 |
Why?
| | Phenotype | 1 | 2004 | 3050 | 0.030 |
Why?
| | Transfection | 2 | 2009 | 895 | 0.030 |
Why?
| | Presynaptic Terminals | 2 | 2006 | 68 | 0.030 |
Why?
| | Embryo, Mammalian | 2 | 2006 | 226 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 579 | 0.030 |
Why?
| | Adolescent | 2 | 2010 | 20213 | 0.030 |
Why?
| | Child | 2 | 2010 | 20721 | 0.030 |
Why?
| | Adult | 3 | 2010 | 35315 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 881 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2006 | 1669 | 0.020 |
Why?
| | Paraneoplastic Syndromes, Nervous System | 1 | 2008 | 12 | 0.020 |
Why?
| | Antigens, Surface | 1 | 2009 | 150 | 0.020 |
Why?
| | Neurocognitive Disorders | 1 | 2008 | 22 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2009 | 157 | 0.020 |
Why?
| | Teratoma | 1 | 2008 | 103 | 0.020 |
Why?
| | Protein Subunits | 1 | 2008 | 231 | 0.020 |
Why?
| | Receptor, EphB2 | 1 | 2006 | 4 | 0.020 |
Why?
| | Receptors, Glutamate | 1 | 2006 | 22 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2006 | 144 | 0.020 |
Why?
| | Mutagenesis | 1 | 2006 | 181 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2009 | 660 | 0.020 |
Why?
| | Middle Aged | 3 | 2015 | 30893 | 0.020 |
Why?
| | Luminescent Proteins | 1 | 2006 | 176 | 0.020 |
Why?
| | Vesicular Glutamate Transport Protein 1 | 1 | 2005 | 3 | 0.020 |
Why?
| | Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2005 | 5 | 0.020 |
Why?
| | Biotinylation | 1 | 2005 | 29 | 0.020 |
Why?
| | Synaptophysin | 1 | 2005 | 15 | 0.020 |
Why?
| | In Situ Nick-End Labeling | 1 | 2005 | 120 | 0.010 |
Why?
| | Nerve Growth Factors | 1 | 2005 | 73 | 0.010 |
Why?
| | Immunotherapy | 1 | 2009 | 585 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2006 | 571 | 0.010 |
Why?
| | Epilepsy | 1 | 2008 | 321 | 0.010 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2005 | 111 | 0.010 |
Why?
| | Electric Stimulation | 1 | 2005 | 269 | 0.010 |
Why?
| | Microtubule-Associated Proteins | 1 | 2005 | 189 | 0.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 425 | 0.010 |
Why?
| | Ovarian Neoplasms | 1 | 2008 | 489 | 0.010 |
Why?
| | Cell Line | 1 | 2008 | 2731 | 0.010 |
Why?
| | Blotting, Western | 1 | 2005 | 1168 | 0.010 |
Why?
| | Proteomics | 1 | 2009 | 1004 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2005 | 1271 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2005 | 2245 | 0.010 |
Why?
| | Aged | 2 | 2009 | 21971 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2009 | 7040 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2005 | 2506 | 0.010 |
Why?
| | Neoplasms | 1 | 2009 | 2465 | 0.010 |
Why?
| | Time Factors | 1 | 2005 | 6503 | 0.010 |
Why?
| | Child, Preschool | 1 | 2008 | 10373 | 0.010 |
Why?
|
|
Hughes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|